[Pharmacoproteomic approach by quantitative targeted proteomics].

Area of Science:

• Proteomics
• Biomarker Discovery
• Pharmacology

Context:

• Traditional omics analyses face limitations in efficiently translating findings into drug development due to their top-down approach.
• The need for streamlined, quantitative protein analysis is critical for advancing drug discovery pipelines.

Purpose:

• To introduce the novel quantitative targeted proteomics method using multiplexed-multiple reaction monitoring (multiplexed-MRM).
• To highlight the technical advantages of multiplexed-MRM for bottom-up proteomics and protein quantification.

Summary:

• The multiplexed-MRM method enables bottom-up proteomics by selecting target proteins and peptides based on existing knowledge and sequence information, bypassing the need for antibody preparation or protein purification.
• This technique allows for simultaneous quantification of multiple proteins, overcoming limitations of antibody-based methods.
• Recent applications demonstrate its utility in analyzing species differences, in vitro-to-in vivo reconstruction, and personalized chemotherapy.

Impact:

• This novel protein quantification method accelerates drug target identification and biomarker discovery.
• It opens new avenues for drug research by enabling a 'Pharmacoproteomics' approach, focusing on protein-level insights.
• The method's efficiency and reduced reliance on traditional techniques promise to improve the translation of omics data into clinical applications.